{"name": "IntegraGen",
 "permalink": "integragen",
 "crunchbase_url": "http://www.crunchbase.com/company/integragen",
 "homepage_url": "http://www.integragen.fr",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "Integragen",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2000,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "33-(0)1-60-91-09-00",
 "description": "",
 "created_at": "Thu Apr 29 03:51:32 UTC 2010",
 "updated_at": "Mon Apr 08 08:02:54 UTC 2013",
 "overview": "\u003Cp\u003EIntegraGen is a French biotech company based on the Genopole life science park in Evry, near Paris. It leverages its unique intellectual property, research expertise and privileged access to sample libraries to develop molecular markers for central nervous system and metabolic diseases. IntegraGen notably uses its proprietary technology platforms to provide genomics services to the pharmaceutical industry, biotech firms and other research providers.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       40],
      "assets/images/resized/0008/5272/85272v1-max-150x150.jpg"],
     [[227,
       61],
      "assets/images/resized/0008/5272/85272v1-max-250x250.jpg"],
     [[227,
       61],
      "assets/images/resized/0008/5272/85272v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": true,
    "title": "Board memeber",
    "person":
     {"first_name": "R\u00e9mi",
      "last_name": "Droller",
      "permalink": "rmi-droller",
      "image":
       {"available_sizes":
         [[[109,
            150],
           "assets/images/resized/0027/5900/275900v1-max-150x150.jpg"],
          [[183,
            250],
           "assets/images/resized/0027/5900/275900v1-max-250x250.jpg"],
          [[230,
            314],
           "assets/images/resized/0027/5900/275900v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u20ac12.4M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.allbusiness.com/services/business-services/3923230-1.html",
    "source_description": "IntegraGen announces EUR 2 million Equity Investment by DSM Venturing",
    "raised_amount": 2000000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2006,
    "funded_month": 11,
    "funded_day": 6,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "DSM Venturing",
         "permalink": "dsm-venturing",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0005/6751/56751v2-max-150x150.png"],
             [[246,
               82],
              "assets/images/resized/0005/6751/56751v2-max-250x250.png"],
             [[246,
               82],
              "assets/images/resized/0005/6751/56751v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://www.bioportfolio.com/biotech_news/Integragen_1.htm",
    "source_description": "INTEGRAGEN COMPLETES Euro8 MILLION FINANCING TO PROGRESS GENETIC TESTS FOR COMPLEX DISEASES, INCLUDING AUTISM AND METABOLIC SYNDROME",
    "raised_amount": 8000000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2005,
    "funded_month": 11,
    "funded_day": 17,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "CDC Enterprises",
         "permalink": "cdc-enterprises-2",
         "image":
          {"available_sizes":
            [[[150,
               58],
              "assets/images/resized/0025/2891/252891v1-max-150x150.jpg"],
             [[240,
               94],
              "assets/images/resized/0025/2891/252891v1-max-250x250.jpg"],
             [[240,
               94],
              "assets/images/resized/0025/2891/252891v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "IDInvest Partners",
         "permalink": "agf-private-equity",
         "image":
          {"available_sizes":
            [[[140,
               60],
              "assets/images/resized/0000/3772/3772v3-max-150x150.png"],
             [[140,
               60],
              "assets/images/resized/0000/3772/3772v3-max-250x250.png"],
             [[140,
               60],
              "assets/images/resized/0000/3772/3772v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Bioam Gestion",
         "permalink": "bioam-gestion",
         "image":
          {"available_sizes":
            [[[150,
               58],
              "assets/images/resized/0008/0192/80192v1-max-150x150.jpg"],
             [[225,
               88],
              "assets/images/resized/0008/0192/80192v1-max-250x250.jpg"],
             [[225,
               88],
              "assets/images/resized/0008/0192/80192v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "SG Asset Management Private Equity",
         "permalink": "sg-asset-management-private-equity-2",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "BayTech Venture Capital",
         "permalink": "baytech-venture-capital-2",
         "image":
          {"available_sizes":
            [[[150,
               145],
              "assets/images/resized/0002/9095/29095v1-max-150x150.jpg"],
             [[155,
               150],
              "assets/images/resized/0002/9095/29095v1-max-250x250.jpg"],
             [[155,
               150],
              "assets/images/resized/0002/9095/29095v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.masshightech.com/stories/2012/07/09/daily51-IntegraGen-collects-24M-to-commercialize-autism-test.html",
    "source_description": "IntegraGen collects $2.4M to commercialize autism test",
    "raised_amount": 2400000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 7,
    "funded_day": 13,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "5 rue Henri Desbru\u00c3\u00a8res",
    "address2": "",
    "zip_code": "Evry",
    "city": "91000",
    "state_code": null,
    "country_code": "FRA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        96],
       "assets/images/resized/0008/5273/85273v1-max-150x150.jpg"],
      [[250,
        160],
       "assets/images/resized/0008/5273/85273v1-max-250x250.jpg"],
      [[450,
        289],
       "assets/images/resized/0008/5273/85273v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}